Desfesoterodine - Docslib

Sign Up
Log In
Upload

Sign Up
Log In
Upload

Home
» Tags
» Desfesoterodine

Desfesoterodine

Muscarinic Acetylcholine Receptor
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
PL112-Final.Pdf
WC No. Date of Issue Valid Till Name of the Firm Address of The
TOVEDESO® DESFESOTERODINE in SYNDROME OVERACTIVE BLADDER Making the Fesoterodine Profitable
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
Muscarinic Acetylcholine Receptor
Literature Search Strategy for Treatment of Stable
INN-Nimet 1 27.11.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
WC No. Date of Issue Valid Till Name of the Firm Address of the Firm Name of Products Irbesartan
WHO Drug Information Vol
Module 1. Signalering – Concept Voor Commentaarronde
Interbiotech Arecoline Bromide
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
ASSAY LIST October 2021
Download Product Insert (PDF)

Top View

Product Data Sheet
Klinische Praktijkrichtlijn Xerostomie En Hyposialie Gerelateerd Aan Medicatie En Polyfarmacie
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
INN-Nimet 1 1.7.2019 a Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum Abagovomabi Abaloparatide Abaloparatidum Abalopara
Marketing Authorisations Granted in July 2017

© 2024 Docslib.org Feedback